Genetic Determinants Involved in the Osteoporosis Pathophysiology

Q4 Pharmacology, Toxicology and Pharmaceutics
Madiha Nooreen, Shafia Fatima, R. Nagarapu, M. Khan, A. Khan
{"title":"Genetic Determinants Involved in the Osteoporosis Pathophysiology","authors":"Madiha Nooreen, Shafia Fatima, R. Nagarapu, M. Khan, A. Khan","doi":"10.2174/1875692117999201211143315","DOIUrl":null,"url":null,"abstract":"\n\nOsteoporosis is a chronic disease characterized by decreased bone mass and\ndistorted microarchitecture that leads to increased bone fragility making an individual\nprone to fractures. It is one of the most widely affected diseases worldwide that has the\npotential to cause serious morbidity, mortality and cost implications. It is a multifactorial\ndisease that is influenced by the interaction between genetic, hormonal, nutritional and\nenvironmental factors. As it is a polygenic disorder, myriad genes influence the disease\ncondition to a varied extent. The identification of genes or loci that effects the development\nof the disease will help not only in individualizing the prognosis, treatment and prevention\nof fractures but also in discovering novel therapeutic agents. The genetic association\nstudies on osteoporosis have reported conflicting results. Well designed and efficiently\nconducted studies with enough power to detect variations in the interaction between\nvarious contributing factors of the disease in the homogenous population are needed to establish\nconclusive genotypic associations with the disease. The present review briefly\nsummarizes the data published on the genes affecting osteoporosis development.\n","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"48 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1875692117999201211143315","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1

Abstract

Osteoporosis is a chronic disease characterized by decreased bone mass and distorted microarchitecture that leads to increased bone fragility making an individual prone to fractures. It is one of the most widely affected diseases worldwide that has the potential to cause serious morbidity, mortality and cost implications. It is a multifactorial disease that is influenced by the interaction between genetic, hormonal, nutritional and environmental factors. As it is a polygenic disorder, myriad genes influence the disease condition to a varied extent. The identification of genes or loci that effects the development of the disease will help not only in individualizing the prognosis, treatment and prevention of fractures but also in discovering novel therapeutic agents. The genetic association studies on osteoporosis have reported conflicting results. Well designed and efficiently conducted studies with enough power to detect variations in the interaction between various contributing factors of the disease in the homogenous population are needed to establish conclusive genotypic associations with the disease. The present review briefly summarizes the data published on the genes affecting osteoporosis development.
参与骨质疏松病理生理的遗传决定因素
骨质疏松症是一种慢性疾病,其特征是骨量减少和微结构扭曲,导致骨脆性增加,使个体容易骨折。它是世界范围内影响最广泛的疾病之一,有可能导致严重的发病率、死亡率和成本问题。它是一种多因素疾病,受遗传、激素、营养和环境因素相互作用的影响。由于它是一种多基因疾病,无数基因在不同程度上影响疾病状况。鉴定影响疾病发展的基因或位点不仅有助于个体化预后、治疗和预防骨折,而且有助于发现新的治疗药物。骨质疏松症的遗传关联研究报告了相互矛盾的结果。在同质人群中,需要精心设计和有效进行的研究,以检测疾病的各种促成因素之间相互作用的变化,以建立与疾病的结论性基因型关联。本文对影响骨质疏松症发生的基因资料进行了综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Pharmacogenomics and Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
0.40
自引率
0.00%
发文量
11
期刊介绍: Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信